Alejandro Sosnik

University of Buenos Aires, Argentina 0000-0003-4704-4599

Alejandro Sosnik received his pharmacy degree from the University of Buenos Aires in 1994 and M.S. (equivalency) and Ph.D. degrees in applied chemistry from the Casali Institute of Applied Chemistry (The Hebrew University of Jerusalem, Israel, 2003). Between 2003 and 2006, Dr. Sosnik spent a postdoctoral stay in the laboratory of Professor Michael Sefton (Institute of Chemical Engineering and Applied Chemistry, University of Toronto, Canada). In 2006, he was appointed as an Adjunct Professor (tenure) of Pharmaceutical Technology at the Faculty of Pharmacy and Biochemistry (University of Buenos Aires) and Investigator (National Science Research Council). He established a research group that works on the interface of biomaterials science, nanotechnology, and drug delivery and targeting. His research interests are focused on the exploration of micro/nanotechnologies for the encapsulation, delivery, and targeting of drugs involved in the pharmacotherapy of HIV, tuberculosis, and other infectious diseases. Dr. Sosnik is the author of over 80 peer-reviewed articles, reviews, editorials, and book chapters and the coinventor in 6 patents and patent applications. He is an Associate Editor of the Journal of Nanopharmaceutics and Drug Delivery and serves in the editorial board of several journals. He edited the theme issue entitled “Nanotechnology solutions for infectious diseases in developing nations” for the journal Advanced Drug Delivery Reviews. Dr. Sosnik is a member of several international scientific societies and he is a founding member of the Argentine Society for Nanomedicines. He is a Visiting Professor and Scientist at the National University of Colombia, the University of Santiago de Compostela, CSIR (South Africa), the National Autonomous University of Mexico, and the Fundació Sant Joan de Déu. He currently coordinates the “Iberoamerican Network of New Materials for the Design of Advanced Drug Delivery Systems in Diseases of High Socioeconomic Impact” (RIMADEL) of the CYTED Program.

Biography Updated on 6 August 2013

Scholarly Contributions [Data Provided by scopus]

download